US Patent Issued to Sedogen on March 31 for "Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a K ATP channel opener" (Illinois Inventor)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,098, issued on March 31, was assigned to Sedogen LLC (Glenview, Ill.).

"Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a K ATP channel opener" was invented by Sara P. Cotter (Wilmette, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to treating Prader-Willi Syndrome (PWS) using a KATP channel opener. The channel opener may be coadministered with other therapies used to treat PWS, such as human growth hormone, a wakefulness promoting agent, or a psychiatric or mood stabilizing drug, thereby allowing the baseline dosages of these other therapies to be d...